Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
Clinical trial NCT02757105 · COMPLETED
Trial details
- NCT number
- NCT02757105
- Sponsor
- RedHill Biopharma Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-19
- Primary completion
- 2017-06-16
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.